Xcel Wealth Management, LLC Bristol Myers Squibb CO Transaction History
Xcel Wealth Management, LLC
- $316 Million
- Q2 2024
A detailed history of Xcel Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Xcel Wealth Management, LLC holds 7,790 shares of BMY stock, worth $418,790. This represents 0.1% of its overall portfolio holdings.
Number of Shares
7,790
Previous 10,455
25.49%
Holding current value
$418,790
Previous $566,000
42.93%
% of portfolio
0.1%
Previous 0.18%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,402Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.53 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.92 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.01 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.18 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $114B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...